Purchase of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Consumables

Tender description

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a type of hyperthermia therapy used in combination with surgery in the treatment of advanced abdominal cancers. The Cardiff and Vale University Health Board completed an open tender procedure in 2022, to purchase the consumables, kit and maintenance required to complete HIPEC and has since received additional funding to continue the treatment process over the next 2 years. Without the repurchase of consumables, the service cannot continue, subsequently, the Health Board would need to send patients elsewhere for treatment. Lot 1: Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a type of hyperthermia therapy used in combination with surgery in the treatment of advanced abdominal cancers. The Cardiff and Vale University Health Board completed an open tender procedure in 2022, to purchase the consumables, kit and maintenance required to complete HIPEC and has since received additional funding to continue the treatment process over the next 2 years. Without the repurchase of consumables, the service cannot continue, subsequently, the Health Board would need to send patients elsewhere for treatment. The original tender was awarded to Gamida LTD after the trial of multiple different supplier’s kit and consumables. The kit was purchased soon after from Gamida LTD. Now that the Health Board has received further funding for HIPEC treatment, there is a need to repurchase the necessary consumables from Gamida LTD to continue the service and treat patients, utilising the current equipment purchased as a result of the tender process. For a continuity of service, the Health Board are direct awarding to Gamida LTD to continue providing the necessary treatment and service to patients.